Short interest for Lovesac gives investors a sense of the degree to which investors are betting on the decline of Lovesac's stock. Short interest data is updated every two weeks.

Lovesac Stock (NASDAQ:LOVE), Short Interest Report

Lovesac

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

elsa-olofsson-12-Zs1xIEtA-unsplash(18)

Cannabis

Earnings

News

LOVE

LOVFF

TSXV:LOVE

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called &#34;a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets.&#34; &#34;Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world,&#34; Sosiak said. &#34;As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis.&#34;

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

Stock Market Data - chart illustration

Long Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

CTRN

RELL

Over $1M Bet On Citi Trends? Check Out These 3 Stocks Insiders Are Buying

earnings banking

PSTL

SNDA

Insiders Buying Lovesac Company And 3 Other Stocks

The Lovesac Co

Love & Health Limited

Love & Health Ltd

LOVE GROUP GLOBAL LTD by LOVE GROUP GLOBAL LTD.

Love Group Global Ltd

LOVE HEMP GROUP PLC by LOVE HEMP GROUP PLC

Love Hemp Group PLC

<p>Stephens &amp; Co.  analyst Trey Grooms   maintains Vulcan Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) with a Overweight and raises the price target from $300 to $310.</p>


Price Target

Analyst Ratings

Stephens & Co. Maintains Overweight on Vulcan Materials, Raises Price Target to $310

<p>JP Morgan  analyst Anupam Rama   maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Overweight and lowers the price target from $177 to $175.</p>


SRPT

JP Morgan Maintains Overweight on Sarepta Therapeutics, Lowers Price Target to $175

<p>Stephens &amp; Co.  analyst Ben Bienvenu   maintains Utz Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) with a Overweight and raises the price target from $21 to $23.</p>


Stephens & Co. Maintains Overweight on Utz Brands, Raises Price Target to $23

<p><strong>James Seyffart</strong>, an ETF research analyst at <strong>Bloomberg Intelligence</strong>, in an interview provided further perspective to the recent launch of spot <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38518143/hong-kongs-bitcoin-etf-debut-records-0-2-of-first-day-us-etf-trading-volume">Bitcoin ETFs in Hong Kong</a>.</p>
<p><strong>What Happened:</strong> In a podcast interview with <strong>Tony Edward</strong>, Seyffart <a href="https://www.youtube.com/watch?v=ZT5DD1klF-0">discussed</a> the recent launch of Bitcoin and Ethereum spot ETFs in Hong Kong, noting that while the volume was underwhelming compared to U.S. trading volume, it&#8217;s a step in the right direction. </p>
<p>&#8220;The benefit is these guys seated with a decent amount of money,&#8221; Seyffart said, referring to the $121 million and $20 million that went into China AMC&#8217;s <strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and <strong>Ethereum </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) ETFs, respectively.</p>
<p>Regarding the U.S. spot Bitcoin ETFs, Seyffart observed that inflows have slowed down, which he considers normal after three months of massive consecutive inflows. </p>
<p>&#8220;Eventually we&#8217;re going to have day after day of net outflows,&#8221; he said, adding that the interest is down but not a mass exodus.</p>
<p><figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" style="width:300px;height:auto" /></a></figure></p>
<p><em>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38616885/bitcoins-clock-is-ticking-why-edward-snowden-issues-final-warning">Bitcoin&#8217;s &#8216;Clock Is Ticking&#8217;: Why Edward Snowden Issues &#8216;Final Warning&#8217;</a></em></p>
<p><strong>Why It Matters:</strong> Seyffart&#8217;s insights shed light on the current state of crypto ETFs and the potential for future growth. </p>
<p>He believes that while the Hong Kong launch may not have been a massive success, it sets the stage for potential future adoption, particularly if mainland Chinese investors are allowed to participate.</p>
<p>In the U.S., Seyffart is not optimistic about the approval of spot Ethereum ETFs in the current cycle. </p>
<p>&#8220;It&#8217;s just not going to happen. There&#8217;s no movement,&#8221; he said, citing a lack of feedback from the SEC to issuers. </p>
<p>He suggests that the SEC might lean on correlation analysis to deny the ETFs, arguing that the spot market is not sufficiently correlated with the Ethereum futures market.</p>
<p>Looking ahead, Seyffart believes that a change in administration or an act of Congress could help move things along more quickly. </p>
<p>He also suggests that SEC Chair <strong>Gary Gensler</strong> might resign in 2025, regardless of the election outcome. </p>
<p>&#8220;I wouldn&#8217;t be shocked&#8230; it seems kind of likely that he would leave within a year after the election,&#8221; Seyffart said.</p>
<p>Seyffart&#8217;s preferred choice for the next SEC Chair is Commissioner <strong>Hester Peirce</strong>, known for her pro-crypto stance. </p>
<p>&#8220;I agree with like 90% of her views from a personal perspective, and I just think it&#8217;s the right way to look at things,&#8221; he said, while acknowledging that it&#8217;s not guaranteed to happen.</p>
<p><strong>What&#8217;s Next</strong>: This topic is set to be a focal point at the upcoming Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19, where industry leaders will gather to discuss the implications of regulatory challenges and the steps necessary to foster a compliant and thriving digital asset ecosystem.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38593141/bitcoin-market-in-distribution-are-we-nearing-a-bottom">Bitcoin Market In Distribution: Are We Nearing A Bottom?</a></em></p>
<p><em>This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</em></p>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Hong Kong Spot Bitcoin ETFs Do Have A 'Benefit,' Bloomberg ETF Analyst Points Out

<p>JP Morgan  analyst Bill Peterson   maintains United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) with a Neutral and lowers the price target from $47 to $43.</p>


JP Morgan Maintains Neutral on United States Steel, Lowers Price Target to $43

<p>Stephens &amp; Co.  analyst Scott Fidel   maintains Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) with a Equal-Weight and raises the price target from $6 to $7.</p>


ALHC

Stephens & Co. Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $7

<p>JP Morgan  analyst John Ivankoe   maintains Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) with a Neutral and lowers the price target from $134 to $132.</p>


JP Morgan Maintains Neutral on Yum Brands, Lowers Price Target to $132

<p>Stephens &amp; Co.  analyst Jack Atkins   maintains Werner Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WERN#NASDAQ">WERN</a>) with a Equal-Weight and lowers the price target from $42 to $40.</p>


WERN

Stephens & Co. Maintains Equal-Weight on Werner Enterprises, Lowers Price Target to $40

<p><strong>Coupang's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) short percent of float has fallen 3.31% since its last report. The company recently reported that it has <strong>28.86 million shares sold short</strong>, which is 2.63% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.03 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Coupang Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714761922_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Coupang has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Coupang's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Coupang's peer group average for short interest as a percentage of float is 9.29%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

CPNG

Peering Into Coupang's Recent Short Interest

<p><strong>Arbor Realty Trust's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) short percent of float has risen 5.74% since its last report. The company recently reported that it has <strong>72.92 million shares sold short</strong>, which is 39.99% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 24.98 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Arbor Realty Trust Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714761916_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Arbor Realty Trust has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Arbor Realty Trust's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Arbor Realty Trust's peer group average for short interest as a percentage of float is 5.25%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Peering Into Arbor Realty Trust's Recent Short Interest

<p><strong>Halliburton's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) short percent of float has risen 22.18% since its last report. The company recently reported that it has <strong>23.74 million shares sold short</strong>, which is 3.58% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.51 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Halliburton Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714761911_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Halliburton has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Halliburton's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Halliburton's peer group average for short interest as a percentage of float is 6.96%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


(HAL) - Analyzing Halliburton's Short Interest

<p>Thursday,&nbsp;<strong>Twist Bioscience Corporation</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) reported a second-quarter EPS loss of $(0.79), better than a loss of $(1.04) a year ago and the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $(0.81)</a>.</p>
<p>The synthetic biology and genomics company reported sales of $75.3 million, up 25% Y/Y, beating the consensus of $70.66 million. Orders increased to $93.2 million, <a href="https://www.benzinga.com/pressreleases/24/05/b38596985/twist-bioscience-reports-fiscal-second-quarter-2024-financial-results" target="_blank" rel="noreferrer noopener">up 45% Y/Y</a>.</p>
<p>Gross margin for the second quarter of fiscal 2024 increased to 41% compared to 31% a year ago. </p>
<p>Shipped products to 2,253 customers, up from 2,100 a year ago. Shipped approximately 193,000 genes, up from approximately 152,000 a year ago.</p>
<p><strong>Guidance:</strong>&nbsp;Twist Bioscience expects third-quarter revenue of $77 million&nbsp;(Est&nbsp;$73.8 million) and $77 million-$80 million for the fourth quarter&nbsp;(Est&nbsp;$77.2 million).</p>
<p>The company raised fiscal year 2024 sales to $300 million-$304 million, compared to $288 million-$293 million and the consensus of $293.1 million.</p>
<p><strong>William Blair</strong>&nbsp;says both SynBio and NGS segment revenue came in above expectations, with SynBio driven by demand for both traditional genes and Express Genes, while&nbsp;NGS demand was driven by customers continuing to move assets into clinical studies as well as new product launches.</p>
<p>The analyst mentions that despite changes in&nbsp;CFO&nbsp;last year affecting past profitability comments, ongoing margin growth and focus on cost control should reassure investors about prioritizing cash preservation.&nbsp;</p>
<p>The narrative of growth and margin expansion, central to the Factory of the Future project,&nbsp;seems to be&nbsp;materializing.&nbsp;William Blair anticipates Twist&#8217;s momentum to persist, projecting revenue growth of over 20% and a gross margin expansion of over 700 basis points annually, continuing into 2025.</p>
<p>William Blair&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/TWST/analyst-ratings" rel="noreferrer noopener">reiterates the Outperform rating</a>.</p>
<p>Other analyst reaction:</p>
<ul>
<li>Baird analyst maintains an Outperform rating&nbsp;and raises&nbsp;the price target from&nbsp;$39&nbsp;to&nbsp;$40.</li>
<li>Barclays keeps an Overweight rating, with an increased price target from $40 to $45.</li>
<li>Evercore ISI Group reiterates the Outperform rating, with a price target of $50, up from $46.</li>
</ul>
<p><strong>Price Action:</strong> TWST shares are up 29.5% at $41.46 at last check Friday.</p>
<p><em>Photo via Shutterstock</em></p>


Analyst Color

Equities

Guidance

Health Care

Reiteration

Movers

General

TWST

Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says

<p>HSBC  analyst Frank Lee   maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Hold and lowers the price target from $56 to $43.</p>


HSBC Maintains Hold on GLOBALFOUNDRIES, Lowers Price Target to $43

<p>Friday,&nbsp;<strong>Amneal Pharmaceuticals Inc</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) announced a significant agreement valued at over $270 million to settle claims related to its alleged contribution to the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/b38608061/amneal-reports-first-quarter-2024-financial-results" rel="noreferrer noopener">opioid crisis in the U.S.</a>&nbsp;</p>
<p>This move positions Amneal as the latest pharmaceutical company to resolve lawsuits brought forth by states, local governments, and Native American tribes concerning the addiction epidemic.</p>
<p>As part of the deal, Amneal has agreed in principle to pay $92.5 million in cash and provide $180 million worth of naloxone nasal spray, an essential medication for treating opioid overdoses.&nbsp;</p>
<p>The agreement, payable over a decade, aims to address a substantial portion of the more than 900 opioid-related lawsuits facing the company, Reuters noted.&nbsp;</p>
<p>Reuters adds that the settlement further contributes to the growing sum of over&nbsp;$51 billion&nbsp;that various stakeholders, including drug manufacturers, distributors, pharmacy operators, and consultants, have agreed to pay to settle lawsuits and investigations related to their involvement in the opioid addiction and overdose crisis.</p>
<p>State attorneys general have accused Amneal of inadequately monitoring and reporting suspicious orders of generic opioid medications by its customers.&nbsp;</p>
<p>Allegations suggest that the company distributed nearly nine billion pills from 2006 to 2019, further exacerbating the crisis.</p>
<p>&#8220;Amneal became one of the largest generic pharmaceutical companies in the world by profiting off the sale of dangerous opioids,&#8221; Reuters noted, citing New York Attorney General Letitia James.</p>
<p>Friday, Amneal Pharmaceuticals&nbsp;reported first-quarter adjusted EPS of $0.14, up from $0.12 a year ago,&nbsp;beating the<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">&nbsp;consensus of $0.09</a>.</p>
<p>The company reported sales of $659.2 million, up 8%, beating the consensus of $619.03 million.</p>
<p>Generics revenues increased by 14% due to strong performance in complex generics, oncology biosimilars, and new launches.&nbsp;</p>
<p>Specialty revenues increased by 15%, driven by promoted products in neurology and endocrinology.&nbsp;</p>
<p>AvKARE revenues increased 33%, driven by continued expansion across its channels due to new products.</p>
<p><strong>Guidance:&nbsp;</strong>Amneal reaffirms fiscal year 2024 revenue guidance of $2.55 billion-$2.65 billion versus the consensus of $2.60 billion, with an adjusted EPS of $0.53-$0.63&nbsp;compared to&nbsp;consensus of $0.58.</p>
<p><strong>Price Action:</strong> AMRX shares are up 9.55% at $6.80 at last check Friday.</p>
<p><em>Photo by Christina Victoria Craft on Unsplash</em></p>


Legal

AMRX

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement

<p>DA Davidson  analyst Peter Heckmann   maintains Q2 Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QTWO#NYSE">QTWO</a>) with a Buy and raises the price target from $58 to $65.</p>


QTWO

DA Davidson Maintains Buy on Q2 Holdings, Raises Price Target to $65

<p>HSBC  analyst Morten Herholdt   maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and raises the price target from $339 to $342.</p>


BIIB

HSBC Maintains Buy on Biogen, Raises Price Target to $342

WIIM

PARA

PARAA

Paramount shares are trading lower following a report suggesting the company expects neither the Skydance or the Sony-Apollo offer to come to fruition.

<p>DA Davidson  analyst Rudy Kessinger   maintains OneSpan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) with a Neutral and raises the price target from $12 to $12.5.</p>


OSPN

DA Davidson Maintains Neutral on OneSpan, Raises Price Target to $12.5

<p>HSBC  analyst Puneet Garg   maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Hold and raises the price target from $240 to $280.</p>


HSBC Maintains Hold on Eaton Corp, Raises Price Target to $280

<p>DA Davidson  analyst Peter Heckmann   maintains Euronet Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) with a Buy and raises the price target from $126 to $136.</p>


EEFT

DA Davidson Maintains Buy on Euronet Worldwide, Raises Price Target to $136

The Lovesac Company (LOVE) Q4 2024 Earnings Call Transcript

For fans of huge modular couches—and admittedly, that is kind of a niche market—Lovesac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) rolled out its earnings report today. Which w...

Lovesac (NASDAQ:LOVE) Rolls Out Earnings, Stock Craters

Oppenheimer analyst Brian Nagel maintained a Buy rating on The Lovesac Company (LOVE – Research Report) today and set a price target of $60.00. The...

The Lovesac Company (LOVE) Receives a Rating Update from a Top Analyst

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Polaris (PII – Research Report) and The Lov...

Analysts Offer Insights on Consumer Cyclical Companies: Polaris (PII) and The Lovesac Company (LOVE)

The Lovesac Co (LOVE) has disclosed a new risk, in the Accounting & Financial Operations category. The Lovesac Co faces significant business risk f...

Lovesac's Financial Turmoil: SEC Probe and Lawsuit Threaten Stability After Restatement Woes

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><a href="https://investorplace.com/industries/technology/artificial-intelligence/">AI stocks</a>, <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a>, and renewable <a href="https://investorplace.com/industries/energy/">energy stocks</a> dominate the list of <a href="https://www.marketwatch.com/tools/screener/short-interest">most shorted stocks</a>, but there also many <a href="https://investorplace.com/industries/consumer-discretionary/">consumer discretionary stocks</a> short sellers are betting against.</p>



<p>There is an excellent reason for this. Even as the U.S. economy remains resilient, despite challenges such as high inflation and high interest rates, a continued &ldquo;soft landing&rdquo; is hardly a guarantee.</p>



<p>As inflation remains elevated, and as <a href="https://www.barrons.com/articles/fed-talk-powell-bostic-speech-rate-cut-inflation-dcf95f67">recent statements from Federal Reserve officials</a> suggest that the central bank is walking back its &ldquo;Fed pivot&rdquo; plans for 2024, high rates may persist longer than expected. In time, this could finally affect economic growth, affecting sectors most hard hit (like consumer discretionary) by such a change.</p>



<p>Alongside macro-related reasons, there are also company-specific reasons the short side is so heavy with certain consumer discretionary stocks. These include poor fundamentals, rich valuations, and other concerns that may snowball into major issues.</p>



<p>Below are the top seven consumer discretionary stocks short sellers are betting against. Let&rsquo;s take a closer look and see whether the bears are on the right or wrong side of the trade.</p>



<h2>Carvana (CVNA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/11/cvna1600-300x169.png" alt="Carvana (CVNA) automobile dealership vending machine. Carvana is an online-only used car dealer."><div>Source: Ken Wolter / Shutterstock.com</div></div><p>Rebounding twelvefold off its 52-week low, <strong>Carvana</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/cvna-stock-quote/"><strong>CVNA</strong></a>) has made short-squeeze traders very rich, but has caused billions in losses for the short-seller community. Yet while one would think this would scare off the bears, that hasn&rsquo;t been the case.</p>



<p>CVNA has continued to have high short interest. At present, around <a href="https://fintel.io/ss/us/cvna">33.8%</a> of the online used car retailer&rsquo;s outstanding float is sold short. While fading Carvana was a losing trade in 2023, and has stayed one thus far in 2024, those betting against that meme stock at today&rsquo;s price could have the last laugh.</p>



<p>While Carvana has been successful in its <a href="https://seekingalpha.com/news/4070713-carvana-shares-rally-company-nears-profitability">efforts to improve gross margins</a>, analyst consensus stills call for net losses to persist <a href="https://www.wsj.com/market-data/quotes/CVNA">through at least 2026</a>. Even if the company hits the top end of estimates, and become consistently profitable, shares trade at a high multiple to peers based on these ambitious forecasts. </p>



<h2>Kura Sushi USA (KRUS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/sushi1600-300x169.jpg" alt="Two rolls of sushi on a platter."><div>Source: Shutterstock</div></div><p><strong>Kura Sushi USA</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/krus-stock-quote/"><strong>KRUS</strong></a>) is another of the top consumer discretionary stocks short sellers are betting against. <a href="https://fintel.io/ss/us/krus">24.7%</a> of the revolving sushi bar operator&rsquo;s outstanding shares have been sold short.</p>



<p>You don&rsquo;t have to look far to determine the bear case for KRUS stock. Yes, Kura Sushi appears to be growing at a rapid clip. Forecasts call for revenue to rise by around <a href="https://seekingalpha.com/symbol/KRUS/earnings">27%</a> next fiscal year (ending August 2025), and for earnings to more than double during that time frame.</p>



<p>However, a valuation of 296.2 times forward earnings is simply too rich, even when taking this fast growth into account. </p>



<p>More importantly, with shares &ldquo;priced to perfection&rdquo; to such a degree, there&rsquo;s a lot more out there that could knock KRUS lower rather than send it higher. Even the reporting of results in line with expectations could drive disappointment, leading to a heavy reversal for shares.</p>



<h2>Kohl&rsquo;s (KSS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kohls-stock-300x169.jpg" alt="Image of Kohl's logo on a Kohl's store"><div>Source: Sundry Photography/Shutterstock.com</div></div><p>At first glance, <strong>Kohl&rsquo;s</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/kss-stock-quote/"><strong>KSS</strong></a>) may seem ripe for a short-squeeze. Shares in the department store chain trade at a low valuation of 10.6 times forward earnings. </p>



<p>With the company&rsquo;s fiscal performance already squeezed by high inflation, you may think that results could improve dramatically, if optimistic forecasts calling for easing inflation play out.</p>



<p>Add in other factors, like <a href="https://seekingalpha.com/news/4063389-kohls-gains-amid-report-activist-pushing-for-sale">activist investor involvement</a>, and you really think KSS stock is a deep value opportunity. However, while well-aware of these positives, the bears who have sold <a href="https://fintel.io/ss/us/kss">31.8%</a> of KSS&rsquo;s outstanding float believe several key negatives will make this would-be deep value play a value trap instead.</p>



<p>Based on the latest guidance, the company expects <a href="https://www.reuters.com/business/retail-consumer/kohls-posts-smaller-drop-holiday-quarter-sales-than-expected-2024-03-12/">further weak results in 2024</a>. As InvestorPlace&rsquo;s Jeremy Flint argued last month, in the years ahead, Kohl&rsquo;s could <a href="https://investorplace.com/2024/03/edge-of-the-abyss-3-stocks-flirting-with-disaster/">end up going the way of <strong>Sears</strong></a>, because of its continued inability to become an omnichannel retailer.</p>



<h2>Luminar Technologies (LAZR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/02/luminar-lazr-1600-sign-300x169.jpg" alt="Luminar (LAZR stock) sign with greenery around it"><div>Source: JHVEPhoto/shutterstock.com</div></div><p>Lidar stocks like <strong>Luminar Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/lazr-stock-quote/"><strong>LAZR</strong></a>) were very popular during the runaway bull market of 2021. Since then, though, these autonomous driving technology plays have fallen fully out of favor.</p>



<p>During this time frame, LAZR stock has fallen by more than 95%, to just over $2 per share. </p>



<p>While the short-side has already profited massively from this trade, many of them have yet to close out positions. At least, based upon the fact <a href="https://fintel.io/ss/us/lazr">26.9%</a> of LAZR&rsquo;s outstanding float remains sold short. Clearly, the shorts see Luminar falling towards zero. </p>



<p>Due to EV demand decline, ongoing high net losses, and dwindling cash, LAZR is a top target for short sellers. While you don&rsquo;t need to short it, take the hint: avoid at all costs.</p>



<h2>Lucid Group (LCID)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/lcid_1600_1934759942-300x169.png" alt="Exterior of Lucid Motors (LCID) building"><div>Source: gg5795 / Shutterstock.com</div></div><p>As I&rsquo;ve argued in past articles discussing <strong>Lucid Group</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/lcid-stock-quote/"><strong>LCID</strong></a>), the bear case is pretty clear-cut. Shares in this early-stage EV manufacturer are in <a href="https://investorplace.com/2024/03/7-nasdaq-stocks-to-sell-in-march-before-they-crash-burn/">a dilution spiral</a>. Lucid has failed to gain traction as a major EV brand. </p>



<p>Production and sales have both fallen far short of initial forecasts. Throw in the curveball of the aforementioned EV growth slump, and Lucid has reported consistently high operating losses as a result. In order to cover these losses, the company has raised capital by selling additional shares of stock.</p>



<p>Primarily, to Lucid&rsquo;s majority owner, Saudi Arabia&rsquo;s Public Investment Fund. As the share count rises, while underlying results don&rsquo;t improve, the per-share value of LCID stock has, and is likely to continue to, decline. With <a href="https://fintel.io/ss/us/lcid">28.9%</a> of LCID&rsquo;s outstanding float sold short, the short seller community has come to a similar conclusion about this down-and-out EV play.</p>



<h2>Lovesac (LOVE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/love1600-300x169.png" alt="Lovesac store sign at Florida Mall in Orlando, Florida, USA. Lovesac is an American furniture retailer, specializing in a patented modular furniture system. LOVE stock."><div>Source: JHVEPhoto / Shutterstock.com</div></div><p>Home furnishings company <strong>Lovesac</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/love-stock-quote/"><strong>LOVE</strong></a>) is one of the consumer discretionary stocks short sellers are betting against. 26.1% of outstanding float has been sold short.</p>



<p>Last summer, I argued that heavily-shorted LOVE stock was a situation where <a href="https://investorplace.com/2023/08/7-retail-stocks-due-for-a-massive-short-squeeze/">going long was a better move than going short</a>. </p>



<p>Lovesac appeared on track to beat expectations, and guide for better times ahead. However, while the company&rsquo;s fiscal results have beat <a href="https://seekingalpha.com/news/4043953-lovesac-jumps-10-after-stronger-than-anticipated-earnings-report">expectations in recent quarters</a>, analysts have walked back expectations for future results.</p>



<p>At one point forecasting earnings of $3 per share for the fiscal year ending January 2025, consensus now calls for earnings of $2.09 per share. Even this reduced forecast could be walked-back further. </p>



<p>As <em>InvestorPlace&rsquo;s</em> Matthew Farley pointed out last month, Lovesac keeps <a href="https://investorplace.com/2024/03/3-sorry-retail-stocks-to-sell-in-march-while-you-still-can/">struggling to improve its margins</a>. Improved results for Loveac may also hinge heavily on a further &ldquo;soft landing&rdquo; for the U.S. economy.</p>



<h2>Wayfair (W)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/wayfair1600-300x169.jpg" alt="The Wayfair (W) logo on the screen of a mobile phone with a purple background"><div>Source: rafapress / Shutterstock.com</div></div><p>Recently, sell-siders have become more bullish about <strong>Wayfair</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/w-stock-quote/"><strong>W</strong></a>). For instance, on April 4, Evercore ISI&rsquo;s Oliver Wintermantel <a href="https://www.barrons.com/articles/wayfair-stock-new-bull-ad629033?mod=md_stockoverview_news">upgraded</a> the home furnishing online retailer&rsquo;s shares to &ldquo;outperform.&rdquo;</p>



<p>In Wintermantel&rsquo;s view, following the company&rsquo;s successful cost reduction efforts, it&rsquo;s well-positioned to report very strong results later this year, as the housing market recovers. </p>



<p>Yet while the Wall Street analyst community is warming back up to W stock, the same can&rsquo;t be said about the so-called &ldquo;smart money&rdquo; short-sellers.</p>



<p>Wayfair has a <a href="https://fintel.io/ss/us/w">23.6%</a> outstanding float sold short. While not certain, this may be because, assuming a comeback does indeed arrive later this year, it&rsquo;s likely more than priced-in by now. </p>



<p>Shares today trade for around <a href="https://seekingalpha.com/symbol/W/earnings">60 times estimated 2024 earnings</a>, and nearly 30 times estimated 2025 earnings. If a late-2024 housing rebound fails to arrive, W may be at risk of a big correction.</p>



<p><em>On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/7-consumer-discretionary-stocks-short-sellers-are-betting-will-fall-from-grace/">7 Consumer Discretionary Stocks Short Sellers are Betting Will Fall from Grace</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Consumer Discretionary Stocks Short Sellers are Betting Will Fall from Grace

The Lovesac Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) has experienced its share of challenges, and the stock has shed a third of its value over the past year. However,...

Is Lovesac's (NASDAQ:LOVE) Recent Stock Slide Overdone?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>At the beginning of 2024, <a href="https://investorplace.com/industries/consumer-discretionary/retail/">retail stocks</a> has a bright outlook. Consumer spending was holding up, the rate of inflation was easing, and there were expectations of an interest-rate cut. &nbsp;</p>



<p>That three-legged stool looks more unstable. The latest reading on inflation showed an uptick that is likely to follow oil prices higher, and Federal Reserve chair Jerome Powell is making it clear that investors should not count on rate cuts anytime soon.&nbsp;</p>



<p>Still, it&rsquo;s not altogether crazy to invest in retail stocks. As the latest retail spending numbers showed, consumer spending is holding up. With late-filing consumers in line to receive their tax refunds in coming weeks, spending will remain strong. &nbsp;</p>



<p>That means some retailers will be in line to report solid earnings. And many of these stocks are offering good value for investors. &nbsp;</p>



<p>This doesn&rsquo;t mean you have to focus on defensive stocks such as consumer staples. But you still want to focus on retail stocks with strong demand, growing earnings, and an e-commerce presence. Here are seven budget-friendly stocks to consider. &nbsp;</p>



<h2>Bath &amp; Body Works (BBWI)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/lb-stock-l-brands-bath-and-bodyworks-300x169.jpg" alt="A Bath &amp; Bodyworks storefront"><div>Source: Shutterstock</div></div><p><strong>Bath &amp; Body Works</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/bbwi-stock-quote/"><strong>BBWI</strong></a></span>) is a well-known specialty retailer of home fragrance, body care, and soaps and sanitizer products. </p>



<p>The company has a loyal customer base which is reflected in a base of approximately <a href="https://investors.bbwinc.com/static-files/ba23a192-feea-4ca2-870d-348de746d368" target="_blank">37 million &ldquo;loyalty&rdquo; customers that accounted for about 80% of the company&rsquo;s sales</a> in 2023. &nbsp;</p>



<p>By almost any meaningful measure: free cash flow, operating margin, net margin, and earnings per share, Bath &amp; Body Works had a solid year in 2023. But the stock is down 5.7% in the month following its fourth quarter and full-year earnings report. </p>



<p>That&rsquo;s because the company forecast slightly lower guidance for 2024. And that guidance was given when the company was expecting near-term interest rate cuts. &nbsp;</p>



<p>However, at 13x forward earnings, BBWI stock is undervalued compared to the <a href="https://yardeni.com/charts/consumer-discretionary-retail-composite/" target="_blank">composite retail average of around 29x</a>. </p>



<p>Analysts are forecasting a <a href="https://www.tradingview.com/chart/aMepJfAr/?symbol=NYSE%3ABBWI&amp;utm_source=www.marketbeat.com&amp;utm_medium=widget&amp;utm_campaign=chart-logo&amp;utm_term=NYSE%3ABBWI" target="_blank">potential 14% upside</a> in the stock price. And if analysts are correct about the 12.7% increase in earnings, investors may also be in line for a dividend increase. &nbsp;</p>



<h2>Target (TGT)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/tgt_1600-300x169.jpg" alt="Image of the Target (TGT) logo on a storefront."><div>Source:  jejim / Shutterstock.com</div></div><p><strong>Target</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/tgt-stock-quote/"><strong>TGT</strong></a></span>) was one of the heavily beaten-down retail stocks in 2023. </p>



<p>However, with the stock off to a 16% gain through mid-April, the stock is now up about 2% in the last 12 months. And there appears to be room for the stock to move higher.&nbsp;</p>



<p>Not all was rosy in the company&rsquo;s fourth quarter earnings report. Year-over-year comparable store sales were down. The same was true for digital sales. But when it came to the metric that matters the most, earnings, the company reported a 58% YOY increase. &nbsp;</p>



<p>It&rsquo;s true that the company offered <a href="https://corporate.target.com/press/release/2024/03/target-corporation-reports-fourth-quarter-and-full-year-2023-earnings" target="_blank">cautious guidance</a>. But that&rsquo;s true for all retailers. TGT stock is attractively valued at 17.5x earnings. </p>



<p>Plus those earnings, even on the low end of the company&rsquo;s guidance easily support an increase to the company&rsquo;s dividend. That would make it 54 consecutive years of increases for Target.&nbsp;</p>



<h2>Foot Locker (FL)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/fl1600-300x169.jpg" alt=""><div>Source: Roman Tiraspolsky / Shutterstock.com</div></div><p><strong>Foot Locker</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/fl-stock-quote/"><strong>FL</strong></a></span>) is in a continued downtrend that&rsquo;s been going on for over two years. FL stock is down 46% in the last 12 months and 29% in 2024. </p>



<p>The latest reason for investors to sour on the retailer was weaker than expected guidance. &nbsp;</p>



<p>However, the latest dip in FL stock may be a case of price discovery. That&rsquo;s because there have been a handful of analyst upgrades since the company reported earnings in March. </p>



<p>Opinions are mixed, but the stock has a <a href="https://www.tradingview.com/chart/aMepJfAr/?symbol=NYSE%3AFL&amp;utm_source=www.marketbeat.com&amp;utm_medium=widget&amp;utm_campaign=chart-logo&amp;utm_term=NYSE%3AFL" target="_blank">consensus price target</a> that points to about 15% share price growth. &nbsp;</p>



<p>A key reason for this change in sentiment came from <strong>Nike</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/nke-stock-quote/"><strong>NKE</strong></a></span>) which accounts for about 65% of Foot Locker&rsquo;s sales. Nike has been moving to a direct-to-consumer model, but in the company&rsquo;s last earnings report, it&rsquo;s now saying it&rsquo;s taking a closer look at its wholesaler strategy. &nbsp;</p>



<p>Foot Locker is also making a pivot to digital and cited an approximately <a href="https://investors.footlocker-inc.com/static-files/d7e633d6-0bb4-416b-89c7-3a7c003c2894" target="_blank">10% growth in YOY digital sales</a>. And the company expects that number to grow by approximately 25% by 2026. &nbsp;</p>



<h2>McDonald&rsquo;s (MCD)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/mcd1600-1-300x169.png" alt="New McDonalds Being Built in 2020, Close Up of Main McD Sign"><div>Source: Retail Photographer / Shutterstock.com</div></div><p><strong>McDonald&rsquo;s</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mcd-stock-quote/"><strong>MCD</strong></a></span>) has been showing up in my social media feeds for the past few months. Some say the prices are too high, others say it&rsquo;s still a value. Those familiar with the business model know that it depends on where you live. </p>



<p>The company is mostly franchisee-owned, and those franchises are free to set their own prices. The point being, how you perceive MCD stock may have a lot to do with how you perceive its value. &nbsp;</p>



<p>Not that pricing isn&rsquo;t an issue. The <a href="https://investorplace.com/2024/04/7-dividend-growth-stocks-to-buy-now-q2-edition/" target="_blank">company acknowledges as much</a>. However, the company&rsquo;s digital game, which it was working on before 2020, is on point, and a way for cash-strapped consumers to get instant daily deals. &nbsp;</p>



<p>Another consistent knock on MCD stock is that growth is behind it. But it should be noted that the company beat revenue and earnings estimates in every quarter in 2023. </p>



<p>The stock is up 38% in the last five years. Not eye-watering growth, but when you add in the dividend, a significant total return for investors. &nbsp;</p>



<h2>Dollar General (DG)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dg1600-300x169.jpg" alt="Dollar General (DG) store front with yellow store sign, midday"><div>Source: Jonathan Weiss / Shutterstock.com</div></div><p>Dollar stores were among the worst-performing retail stocks in 2023. And <strong>Dollar General</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/dg-stock-quote/"><strong>DG</strong></a></span>) was no exception. </p>



<p>This reflects the effect that inflation has on the low-income consumers that are a core base of the dollar store model. &nbsp;</p>



<p>But after a double beat on earnings in March, investors are starting to see the value of DG stock. It&rsquo;s true that higher-for-longer interest rates are a headwind. But as the company&rsquo;s earnings report shows, investors may be too negative. &nbsp;</p>



<p>One reason that I&rsquo;ve mentioned before is the company&rsquo;s <a href="https://investorplace.com/2024/04/forget-the-bad-cpi-news-buy-the-dip-in-these-3-runaway-earnings-winners/" target="_blank">strategy regarding store location</a>. The company ensures it&rsquo;s located in rural areas and other spots not easily serviced by big-box retailers. &nbsp;</p>



<p>But that doesn&rsquo;t mean Dollar General isn&rsquo;t leaning into digital. The company has ramped up its digital presence with MyDG which gives consumers access to online-only coupons. In 2023, the company reported <a href="https://ecommercedb.com/store/dollargeneral.com" target="_blank">$381.3 million in digital sales</a>. This was comparable to 2020, which shows that the pivot is going well. &nbsp;</p>



<p>In times of ongoing market volatility, you should be looking for <a href="https://investorplace.com/stock-types/undervalued-stocks/">undervalued stocks</a> that are best in class. DG stock checks that box. &nbsp;</p>



<h2>Tractor Supply Company (TSCO)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/TSCO1600-300x169.jpg" alt="A Tractor Supply Co. Store"><div>Source: Shutterstock</div></div><p><strong>Tractor Supply Company </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/tsco-stock-quote/"><strong>TSCO</strong></a></span>) is a rural lifestyle retailer with over 2,200 stores in 49 states. </p>



<p>The company has been delivering mixed revenue and earnings results over the last year. TSCO stock is up 139% over the last five years. However, it&rsquo;s only up about 1% in the last 12 months and that&rsquo;s because of the 15% rally in 2024. &nbsp;</p>



<p>But this is a time to remember why you want to own a quality dividend stock. In February, the company raised its dividend for the fifteenth consecutive year. It&rsquo;s been growing the dividend at around a 40% average over the last three years, but still has a sustainable payout ratio of around 48%. &nbsp;</p>



<p>There are a lot of reasons to like Tractor Supply Company as an undervalued retail stock. But the price action on TSCO stock shows that the stock recently broke above a level of resistance at $248. </p>



<p>After a pullback, that price is now being tested as a line of support. A bullish earnings report in late April may be the fuel that the stock needs to take the next leg higher.&nbsp;</p>



<h2>Lovesac (LOVE)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/03/love-stock-1-300x169.jpg" alt="lovesac storefront"><div>Source: BCFC / Shutterstock.com</div></div><p><strong>Lovesac </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/love-stock-quote/"><strong>LOVE</strong></a></span>) rounds out this list of budget-friendly retail stocks. This is no value stock. Lovesact is a young company that is still in the expansion phase. </p>



<p>In its most recent quarter, it gave mixed results, but one shining star was expanding margins. That had been a problem for the company. &nbsp;</p>



<p>One time doesn&rsquo;t make a pattern. But it should allow investors to focus on other <a href="https://d1io3yog0oux5.cloudfront.net/_7862ad9fd4f4221bf0e66edcd2ae0f5c/lovesac/db/781/6928/pdf/LOVE+Q3+FYE+2024+Investor+Presentation+%28Final%29.pdf" target="_blank">positive developments</a> such as a 15% increase in store count, positive cash flow that almost doubled between 2022 and 2023. That highlights the company&rsquo;s inventory reduction that puts Lovesac in a good position as it waits for a more favorable monetary environment. &nbsp;</p>



<p>Short interest of over 30% is concerning. But institutional investors own 92% of the stock&rsquo;s float and the overwhelming sentiment is bullish. That means investors with some appetite for speculation could see a small position slingshot higher if the company continues to deliver strong earnings. &nbsp;</p>



<p><em>On the date of publication, Chris Markoch had a LONG position in MCD. The opinions expressed in this article are those of the writer, subject to the </em>InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a><em>.</em>&nbsp;</p>
<div><p>Chris Markoch is a freelance financial copywriter who has been covering the market for over five years. He has been writing for InvestorPlace since 2019.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/7-budget-friendly-retail-plays-due-for-a-tax-refund-spending-boost/">7 Budget-Friendly Retail Plays Due for a Tax Refund Spending Boost</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Budget-Friendly Retail Plays Due for a Tax Refund Spending Boost

There's a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Red Robin Gourmet (RRGB – Research Report) an...

Analysts Are Bullish on These Consumer Cyclical Stocks: Red Robin Gourmet (RRGB), The Lovesac Company (LOVE)

There's a lot to be optimistic about in the Consumer Cyclical sector as 3 analysts just weighed in on The Lovesac Company (LOVE – Research Report),...

Analysts' Top Consumer Cyclical Picks: The Lovesac Company (LOVE), Restaurant Brands International (QSR)

AMZN

BBWI

CVNA

KRUS

LAZR

LCID

RRGB

TSCO

Small Cap

Press Releases

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Lovesac Company (LOVE)

LOVESAC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Lovesac Company and Encourages Investors to Contact the Firm

LOVE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Lovesac Company Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action – LOVE

LOVE DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages The Lovesac Company Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - LOVE

LOVE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Lovesac Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

DEADLINE ALERT for GDHG, LOVE, INSP, and DRVN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in The Lovesac Company of Class Action Lawsuit and Upcoming Deadlines – LOVE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lovesac Stock (NASDAQ:LOVE), Short Interest Report

People Also Watch